The largest database of trusted experimental protocols

Rvegf

Manufactured by Merck Group
Sourced in Macao

RVEGF is a laboratory equipment product manufactured by Merck Group. It is designed to measure and analyze vascular endothelial growth factor (VEGF) levels in biological samples. The core function of RVEGF is to provide accurate and reliable VEGF quantification to support research and development in areas such as angiogenesis, cancer biology, and cardiovascular studies.

Automatically generated - may contain errors

2 protocols using rvegf

1

Rat BMSC Isolation and Transfection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rat BMSCs were isolated from the femurs and tibias of male Wistar rats (90–100 g) as described earlier with modification [24 (link)]. Rats were killed by intravenous injection of ketamine/xylazine, and all work was performed according to the Institutional Animal Care and Use Committee guidelines. This experimental protocol was reviewed and approved by the Medical Ethics Committee of Shandong University School of Medicine. Briefly, the cells were seeded in Dulbecco's modified Eagle's medium low glucose (Gibco, USA) supplemented with 15% fetal bovine serum and fibroblast growth factor 2 (FGF-2) (Beifuji, China), 10 ng/mL, at 37°C in humidified air with 5% CO2. Rat BMSCs were phenotypically characterized as described [25 (link)]. Cells were transfected with pCMV6 empty vector/pCMV6-CD163 in DMEM with FGF-2 (10 ng/mL), rVEGF (10 ng/mL) (Sigma, St. Louis, MO), and 2% serum and incubated at 37°C for 24 h. Then, the medium is replaced by basal DMEM with FGF-2 (10 ng/mL) and rVEGF (10 ng/mL) incubated at 37°C for another 24 h.
+ Open protocol
+ Expand
2

A. platensis Extract Preparation and Use

Check if the same lab product or an alternative is used in the 5 most similar protocols
The A platensis was purchased from Martin Bauer GmbH (Vestenbergsgreuth, Germany). The water extract of both A platensis and phycocyanobilin was prepared as has been previously described elsewhere.4 The cell culture media and non‐essential amino acids (NEAAs) were obtained from Sigma‐Aldrich, and the other cell culture components were from Biosera (Nuaille, France). The serine/threonine phosphatase and protease inhibitor cocktails were purchased from either Sigma‐Aldrich or Serva. The Geltrex™ LDEV‐Free Reduced Growth Factor Basement Membrane Matrix was purchased from Thermo Fisher Scientific. The recombinant growth factors and inhibitors were procured as follows: rVEGF, rEGF (epidermal growth factor), rAREG (amphiregulin, autocrine mitogen related to EGF), rHGF/SF (hepatocyte growth factor/scatter factor), PD 0325901 (all from Sigma‐Aldrich), erlotinib (Cell Signaling Technology), vatalanib and axitinib (Selleck Chemicals) and bevacizumab (LGM Pharma). Unless otherwise specified, all other common chemicals were from Sigma‐Aldrich.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!